These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 10520975

  • 21. An open pilot study combining risperidone and a selective serotonin reuptake inhibitor as initial antidepressant therapy.
    Hirose S, Ashby CR.
    J Clin Psychiatry; 2002 Aug; 63(8):733-6. PubMed ID: 12197455
    [Abstract] [Full Text] [Related]

  • 22. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
    Appelberg BG, Syvälahti EK, Koskinen TE, Mehtonen OP, Muhonen TT, Naukkarinen HH.
    J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
    [Abstract] [Full Text] [Related]

  • 23. Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression.
    Costa e Silva J.
    J Clin Psychiatry; 1998 Jul; 59(7):352-7. PubMed ID: 9714263
    [Abstract] [Full Text] [Related]

  • 24. Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.
    Stahl SM, Entsuah R, Rudolph RL.
    Biol Psychiatry; 2002 Dec 15; 52(12):1166-74. PubMed ID: 12488062
    [Abstract] [Full Text] [Related]

  • 25. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes.
    Barbosa L, Berk M, Vorster M.
    J Clin Psychiatry; 2003 Apr 15; 64(4):403-7. PubMed ID: 12716240
    [Abstract] [Full Text] [Related]

  • 26. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.
    Pollack MH, Zaninelli R, Goddard A, McCafferty JP, Bellew KM, Burnham DB, Iyengar MK.
    J Clin Psychiatry; 2001 May 15; 62(5):350-7. PubMed ID: 11411817
    [Abstract] [Full Text] [Related]

  • 27. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.
    Bennie EH, Mullin JM, Martindale JJ.
    J Clin Psychiatry; 1995 Jun 15; 56(6):229-37. PubMed ID: 7775364
    [Abstract] [Full Text] [Related]

  • 28. Venlafaxine in the treatment of postpartum depression.
    Cohen LS, Viguera AC, Bouffard SM, Nonacs RM, Morabito C, Collins MH, Ablon JS.
    J Clin Psychiatry; 2001 Aug 15; 62(8):592-6. PubMed ID: 11561929
    [Abstract] [Full Text] [Related]

  • 29. Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study.
    McIntyre A, Gendron A, McIntyre A.
    Depress Anxiety; 2007 Aug 15; 24(7):487-94. PubMed ID: 17177199
    [Abstract] [Full Text] [Related]

  • 30. A double-blind placebo-controlled study of controlled release fluvoxamine for the treatment of generalized social anxiety disorder.
    Westenberg HG, Stein DJ, Yang H, Li D, Barbato LM.
    J Clin Psychopharmacol; 2004 Feb 15; 24(1):49-55. PubMed ID: 14709947
    [Abstract] [Full Text] [Related]

  • 31. Residual symptoms in depressed patients who respond acutely to fluoxetine.
    Nierenberg AA, Keefe BR, Leslie VC, Alpert JE, Pava JA, Worthington JJ, Rosenbaum JF, Fava M.
    J Clin Psychiatry; 1999 Apr 15; 60(4):221-5. PubMed ID: 10221281
    [Abstract] [Full Text] [Related]

  • 32. Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response.
    Perugi G, Frare F, Toni C, Ruffolo G, Torti C.
    Neuropsychobiology; 2002 Apr 15; 46(3):145-9. PubMed ID: 12422062
    [Abstract] [Full Text] [Related]

  • 33. A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group.
    Ravindran AV, Judge R, Hunter BN, Bray J, Morton NH.
    J Clin Psychiatry; 1997 Mar 15; 58(3):112-8. PubMed ID: 9108813
    [Abstract] [Full Text] [Related]

  • 34. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE, Franznick DA, Hollander SB, Fava M.
    J Clin Psychiatry; 2004 Aug 15; 65(8):1069-75. PubMed ID: 15323591
    [Abstract] [Full Text] [Related]

  • 35. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
    Hirschfeld RM, Weisler RH, Raines SR, Macfadden W, BOLDER Study Group.
    J Clin Psychiatry; 2006 Mar 15; 67(3):355-62. PubMed ID: 16649820
    [Abstract] [Full Text] [Related]

  • 36. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.
    Feighner JP, Overø K.
    J Clin Psychiatry; 1999 Dec 15; 60(12):824-30. PubMed ID: 10665628
    [Abstract] [Full Text] [Related]

  • 37. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ, Jiang Q.
    Int Clin Psychopharmacol; 2008 May 15; 23(3):113-9. PubMed ID: 18408525
    [Abstract] [Full Text] [Related]

  • 38. A comparison of fluvoxamine and fluoxetine in the treatment of major depression.
    Rapaport M, Coccaro E, Sheline Y, Perse T, Holland P, Fabre L, Bradford D.
    J Clin Psychopharmacol; 1996 Oct 15; 16(5):373-8. PubMed ID: 8889909
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients.
    Feighner JP, Entsuah AR, McPherson MK.
    J Affect Disord; 1998 Jan 15; 47(1-3):55-62. PubMed ID: 9476744
    [Abstract] [Full Text] [Related]

  • 40. Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients.
    Fabre L, Birkhimer LJ, Zaborny BA, Wong LF, Kapik BM.
    Int Clin Psychopharmacol; 1996 Jun 15; 11(2):119-27. PubMed ID: 8803649
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.